BUZZ - Ardent Health shares fall after launching secondary public offering
路透社2026/11/18 01:47Content updated to reflect the company's corrected press release regarding the sale of shareholder holdings
November 18 - ** Hospital operator Ardent Health (ARDT.N) fell 14.9% in after-hours trading to $15.10 after news that the company will conduct a secondary offering
** ARDT (link) launches an offering of 8 million shares; an affiliate of Equity Group Investments (EGI) will sell about 7.1 million shares, and an affiliate of Ventas VTR.N will sell 863,281 shares
** In addition, as part of this offering, ARDT plans to simultaneously repurchase up to 1.5 million shares from the underwriters
** JPMorgan and Barclays are leading the offering, with seven additional bookrunners participating
** According to the prospectus, EGI-AM Investments currently holds a 54.8% stake in ARDT and Ventas holds a 6.6% stake (link)
** ARDT, headquartered in Brentwood, Tennessee, currently has about 140.9 million shares outstanding
** The stock closed down 1.9% on Tuesday at $17.75; in November, the share price surged 47.5% and has approximately doubled year-to-date
** According to LSEG data, the average rating from 13 analysts is "buy"; the median price target is $18, up from $13 a month ago
(To assist non-English speakers, Reuters automates the translation of its reports into multiple other languages. As automated translation may contain errors or lack required context, Reuters does not guarantee the accuracy of the automated translation text, and it is provided solely for readers' convenience. Reuters accepts no liability for any damage or loss arising from the use of automated translation functionality.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like

SpaceX plans to issue $6 billion in bonds on Thursday, completing its total $32 billion bond financing to purchase Nvidia chips.
According to media reports, the current offering includes approximately $6 billion in bonds, increased from the previous $4 billion, and was opened to investors for subscription on Thursday. The remaining approximately $26 billion in notes have already been allocated. The funds will be used by a special purpose vehicle called Saturn Funding Trust to purchase NVIDIA AI chips, which SpaceX will initially use under a five-year lease agreement.

Hunterbrook short-selling report strikes AMD! Claims of wash trading and promised scale far exceeding Nvidia, AMD denies allegations
Hunterbrook Capital stated that AMD provides financing and guarantees to companies purchasing its chips, with the committed scale already far surpassing Nvidia, yet its cash reserves are relatively insufficient. The report also pointed out that some of the product lines AMD relies on for growth may face strict export controls. AMD responded by stating that the Hunterbrook report misrepresented AMD's business practices and partnerships. After the report was released, AMD experienced an intraday drop of up to 11%.

Bloomberg Economists: Anthropic's IPO May Signal the End of the AI Boom
Bloomberg economist Anna Wong believes that Anthropic's actual price per million tokens has dropped significantly since September. Although token usage has surged, its market share has actually declined, indicating that its technological edge has not translated into lasting pricing power. An IPO would bring the pricing and profit margins of cutting-edge AI into the public market for quarterly scrutiny; if its pricing power is weaker than what is implied by its valuation, the AI sector might see an accelerated correction in valuations.